Fifth indication for seizure drug approved
Lamotrigine (Lamictal) has been approved for its fifth indication as an antiepileptic—this time as an add-on therapy to treat primary generalized tonic-clonic seizures in children two years of age and older and adults.
Lamotrigine (Lamictal) has been approved for its fifth indication as an antiepilepticthis time as an add-on therapy to treat primary generalized tonic-clonic seizures in children two years of age and older and adults. The drug is also approved as a maintenance treatment for bipolar I disorder in adults.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA Approves Lebrikizumab-lbkz for Moderate-to-Severe Atopic Dermatitis
September 16th 2024Lebrikizumab-lbks is a targeted treatment that addresses the root cause of atopic dermatitis; by reducing inflammation throughout the body, it can help alleviate the dry, itchy, and irritated skin that often characterizes the condition.
